EULAV Asset Management’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,400
| Closed | -$352K | – | 190 |
|
|
2023
Q1 | $352K | Sell |
3,400
-3,400
| -50% | -$352K | 0.01% | 192 |
|
|
2022
Q4 | $784K | Hold |
6,800
| – | – | 0.03% | 191 |
|
|
2022
Q3 | $737K | Sell |
6,800
-13
| -0.2% | -$1.41K | 0.03% | 193 |
|
|
2022
Q2 | $1.23M | Buy |
6,813
+399
| +6% | +$72K | 0.05% | 193 |
|
|
2022
Q1 | $1.1M | Buy |
6,414
+2
| +0% | +$341 | 0.03% | 210 |
|
|
2021
Q4 | $1.38M | Buy |
6,412
+1
| +0% | +$216 | 0.03% | 211 |
|
|
2021
Q3 | $1.24M | Hold |
6,411
| – | – | 0.03% | 208 |
|
|
2021
Q2 | $1.81M | Hold |
6,411
| – | – | 0.05% | 200 |
|
|
2021
Q1 | $1.36M | Hold |
6,411
| – | – | 0.04% | 220 |
|
|
2020
Q4 | $1.26M | Buy |
6,411
+11
| +0.2% | +$2.16K | 0.03% | 227 |
|
|
2020
Q3 | $1.05M | Sell |
6,400
-16
| -0.2% | -$2.63K | 0.03% | 231 |
|
|
2020
Q2 | $890K | Buy |
6,416
+16
| +0.3% | +$2.22K | 0.03% | 237 |
|
|
2020
Q1 | $400K | Sell |
6,400
-6,200
| -49% | -$388K | 0.02% | 246 |
|
|
2019
Q4 | $1.38M | Sell |
12,600
-5,700
| -31% | -$625K | 0.05% | 234 |
|
|
2019
Q3 | $1.9M | Hold |
18,300
| – | – | 0.07% | 219 |
|
|
2019
Q2 | $2.35M | Buy |
18,300
+6,900
| +61% | +$885K | 0.09% | 201 |
|
|
2019
Q1 | $1.49M | Hold |
11,400
| – | – | 0.06% | 227 |
|
|
2018
Q4 | $1.43M | Hold |
11,400
| – | – | 0.07% | 215 |
|
|
2018
Q3 | $2.53M | Hold |
11,400
| – | – | 0.11% | 178 |
|
|
2018
Q2 | $1.83M | Buy |
11,400
+900
| +9% | +$144K | 0.08% | 201 |
|
|
2018
Q1 | $981K | Buy |
+10,500
| New | +$981K | 0.05% | 228 |
|